-
The Multiple Roles and Therapeutic Potential of Clusterin in Non-Small-Cell Lung Cancer
A better understanding of the clinical relevance of clusterin in non-small cell lung cancer could lead to the development of more effective targeted therapies.
December 01, 2021
-
Surgery for Advanced-Stage Non-Small Cell Lung Cancer: Lobectomy or Sub-Lobar Resection?
Which of these two surgical options provide a greater survival benefit in metastatic non-small cell lung cancer?
November 01, 2021
-
Inhaled Corticosteroids and Risk of Lung Cancer Among Chronic Obstructive Pulmonary Disease Patients
What role might inhaled corticosteroids have in the risk for lung cancer among COPD patients? Is there a protective effect?
October 01, 2021
-
Liquid Biopsy in Non-Small Cell Lung Cancer -- Current Status and Future Outlook
In this review, the current role and possible future applications of liquid biopsy in the management of non-small cell lung cancer are explored.
September 02, 2021
-
Neoadjuvant Chemoimmunotherapy in Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
Is the use of neoadjuvant immunotherapy combined with chemotherapy a safe and effective therapeutic option for patients with resectable non-small cell lung cancer?
August 02, 2021
-
Combining Radiotherapy With Targeted Therapies in Non-Small Cell Lung Cancer
Combining radiotherapy with targeted agents could be a promising therapeutic strategy for non-small cell lung cancer.
July 02, 2021
-
Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer
A new review explores the current role of stereotactic body radiation therapy in the treatment of early stage non-small cell lung cancer and highlights recent research.
June 02, 2021
-
Latest CT Technologies in Lung Cancer Screening
This article provides an overview of current protocol recommendations in CT lung cancer screening and the latest dose reduction techniques.
May 20, 2021
-
Novel Risk Scoring System for Immune Checkpoint Inhibitors Treatment in Non-Small Cell Lung Cancer
Learn more about this newly developed scoring system for the risk stratification of NSCLC patients treated with immune checkpoint inhibitors.
May 13, 2021
-
Narrative Review of Lung Cancer Treatment at the Time of COVID-19 Pandemia
In what ways has the COVID-19 pandemic impacted the care of lung cancer patients?
May 06, 2021
-
Association Between Dietary Sodium, Potassium Intake and Lung Cancer Risk
What role might dietary sodium and potassium intake have in the risk for developing lung cancer?
April 29, 2021
-
Expert Consensus on Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer
A new expert consensus provides guidance regarding the use of neoadjuvant immunotherapy in NSCLC.
April 22, 2021
-
Survival Benefit and Toxicity Profile of Adjuvant Icotinib for Patients With EGFR Mutation-Positive Non-Small Cell Lung Carcinoma
Might the use of adjuvant icotinib improve survival among EGFR mutation-positive NSCLC patients? What do we know about the treatment-related toxicities?
April 15, 2021
-
A Narrative Review of Lung Cancer Cytology in the Times of Coronavirus
Cytopathology plays a key role in the diagnosis and management of lung cancer. In what ways has the current pandemic impacted the handling and processing of these samples?
February 04, 2021
-
Treatments for Combined Small Cell Lung Cancer Patients
Which treatment strategies should be considered for this rare subtype of small cell lung cancer?
January 04, 2021
-
Recent Trends in Use of Adjuvant Chemotherapy in Elderly Stage II-III Non-Small Cell Lung Cancer
A new study examined recent trends in the patterns of use of adjuvant chemotherapy among elderly patients with lung cancer. What have we learned?
December 04, 2020
-
Uniportal Video-Assisted Thoracic Surgery for the Treatment of Lung Cancer
Should this procedure have a role in the treatment of lung cancer? A new consensus statement provides guidance and recommendations.
November 05, 2020
-
Integrating Clinical and Biological Prognostic Biomarkers in Patients With Advanced NSCLC Treated With Immunotherapy
What can these potential biomarkers tell us about the prognosis of immunotherapy-treated non-small cell lung cancer?
October 05, 2020
-
Role of Chest Radiographs in Early Lung Cancer Detection
Low-dose CT is traditionally used in the screening of patients at risk for lung cancer, but it has its limitations. Might chest radiography provide a viable alternative?
September 04, 2020
-
Feasibility and Safety of PD-1/L1 Inhibitors for Non-Small Cell Lung Cancer in Front-Line Treatment
Are PD-1/L1 inhibitors a safe and effective option for the front line treatment of patients with advanced non-small cell lung cancer?
August 07, 2020
